Rocket Lab (RKLB) has outperformed its aerospace-defense industry peers with a 23.5% gain over the past year, driven by strong revenue growth (66.4% YoY), record backlog of $3.57 billion, and expanding spacecraft manufacturing. However, the stock trades at a significant premium valuation (29.91X forward P/S vs. 7.01X industry average), faces continued losses ($174M in 9M 2026), and execution risks with Neutron rocket delays. New investors should wait for better entry points, while current holders may stay invested given strong liquidity and low debt levels.